Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00004097 · National Cancer Institute (NCI), NIH · Unknown status
Key facts
| NCT number | NCT00004097 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer |
| Official title | A Phase I Study of Concomitant Chemoradiotherapy With Gemcitabine, Paclitaxel, and 5-FU for Patients With Advanced and/or Recurrent Cancer of the Head and Neck |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | fluorouracil, gemcitabine hydrochloride, paclitaxel, radiation therapy |
| Start date | Aug 1, 1999 |
| First posted | Mar 31, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: